Bayer, National Heart Center Singapore to develop explorative cardiovascular center
By Anh Nguyen  December 22, 2020 | 04:43 pm GMT+7
Bayer and National Heart Center Singapore (NHCS) announced they had inked a five-year agreement to develop a “Center of Excellence for Explorative Cardiovascular Studies.”
The center aims to boost patient-centricity in research and development (R&D) and improve treatment outcomes in cardiovascular disease (CVD) management.
Combining NHCS’s vast experience in managing Asian CVD patients and clinical research with Bayer’s expertise in pharmaceutical R&D, the center will generate and integrate high quality patient data into early clinical research that would allow better understanding of the underlying biology of CVDs. Results could potentially lead to future targeted therapies to address unmet medical needs in defined patient populations. Bayer will contribute S$5.4 million ($4 million) towards the setup of the center.
NHL season set: Red Wings will play in Central division
clickondetroit.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from clickondetroit.com Daily Mail and Mail on Sunday newspapers.
Bayer and NHCS to set up Center of Excellence for Explorative Cardiovascular Studies
vir.com.vn - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from vir.com.vn Daily Mail and Mail on Sunday newspapers.